📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial. (2023)

First Author: Rosu L

Attributed to: Respiratory infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(22)00498-3

PubMed Identifier: 36565704

Publication URI: http://europepmc.org/abstract/MED/36565704

Type: Journal Article/Review

Volume: 11

Parent Publication: The Lancet. Global health

Issue: 2

ISSN: 2214-109X